SEATTLE, WA -- (Marketwired) -- 11/05/14 -- , an emerging leader in molecular diagnostics, today announced…
Continue ReadingTag: integrated-diagnostics
Indi Molecular Expands Seed Round to $1.8 Million With Additional $300K From Asset Management Ventures
Company Publishes Three New Papers in Collaboration With Caltech to Further the Development of Synthetic Replacement…
Continue ReadingIndi(R) Announces Availability of Xpresys(TM) Lung Blood Test With Potential to Help Physicians Identify More Lung Nodules as Likely Benign and More Patients as Possible Candidates for Active Surveillance Instead of Invasive Procedures
Using Innovative Strategy, Test Does NOT Seek to Identify Lung Cancer; It Is ONLY Intended to…
Continue ReadingIndi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partners
Pre-Eminent Team Backs Potential Replacement for Antibodies; Spinout From Integrated Diagnostics Will Further Develop New Binding…
Continue ReadingIntegrated Diagnostics(R) Appoints CFO & VP Sales Prior to Launch of Lung Cancer Diagnostic
John Bencich Appointed Chief Financial Officer; Jill Tonachio Is Vice President for Sales
Continue ReadingIntegrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
Company Appoints CFO and CBO, Completing Executive Team
Continue Reading